Exclusive Toll Brothers community with breathtaking views and luxurious home designs opens brand new model home in Sedona, ArizonaSEDONA, Ariz., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced the grand opening of its highly anticipated new model home at Toll Brothers at Sedona, an exquisite new home community in the serene and world-renowned town of Sedona, Arizona. The public is invited to tour the new model home and availabl ...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, Canada, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or the “Company”) is pleased to announce a non-brokered private placement (the “Offering”) of up to 18,000,000 units of the Company (each, a “Unit”) at a price of US$0.20 (approximately CDN$0.276) per Unit for gross proceeds of up to US$3,600,000. Each Unit will consist of one common share of the Company (each, ...

Core Viewpoint - The Minnesota Zoo, John Ball Zoo, and Assiniboine Park Conservancy have been awarded the 2025 North American Conservation Award by the Association of Zoos and Aquariums (AZA) for their collaborative efforts in the recovery of the critically endangered Poweshiek skipperling butterfly [1][10]. Group 1: Conservation Efforts - The Poweshiek skipperling has seen a dramatic decline in population, disappearing from most of its historical range due to habitat loss, with the last sighting in Minnesota occurring in 2007 [2][6]. - The collaborative efforts of the Minnesota Zoo, John Ball Zoo, and Assiniboine Park Conservancy have led to the development of breeding protocols, resulting in the release of thousands of butterflies to stabilize and grow the remaining populations [3][7]. - The U.S. population of the Poweshiek skipperling is now believed to be derived from just 18 females that were in zoo care at the start of the breeding program [3][6]. Group 2: Achievements and Recognition - The conservation biologists from the Minnesota Zoo have been recognized as 2024 Recovery Champions by the U.S. Fish and Wildlife Service for their leadership in these efforts [5]. - The AZA award highlights the importance of sustained, collaborative conservation efforts and the role of accredited zoos in species recovery [8][10]. - Measurable progress has been observed in 2024 and 2025, including verified persistence at reintroduction sites and a significant increase in wild sightings of the Poweshiek skipperling [9]. Group 3: Research and Collaboration - Cutting-edge research has been conducted, including a unique wing-marking technique for tracking, whole genome sequencing, and studies on threats like pesticide exposure and climate change [7]. - The Poweshiek Skipperling International Partnership has been established to align various government, academic, and community partners across borders for effective conservation [7].

Core Viewpoint - Scilex Holding Company has announced a strategic investment of $150 million in Bitcoin in Datavault AI Inc. to support its growth in supercomputing infrastructure and data monetization [1][3]. Company Overview - Scilex is focused on acquiring, developing, and commercializing non-opioid pain management products for acute and chronic pain, as well as neurodegenerative and cardiometabolic diseases [6][7]. - Datavault AI is positioned to leverage AI-driven analytics and blockchain technology to address challenges in data integrity and monetization across various industries, including biotech and energy [2][11]. Investment Details - The investment will provide Datavault with growth capital to expand its operations and unlock new revenue streams [1]. - Scilex is expected to receive up to 278,914,094 shares of Datavault common stock at an effective purchase price of $0.5378 per share, with specific terms regarding share issuance and board representation [4]. Market Potential - The global AI market is projected to reach $1.8 trillion by 2030, while the life sciences analytics market is estimated at $35.69 billion in 2024, growing at an 11.4% CAGR through 2030 [2]. - The biotech data monetization market is expected to reach a size of $30-50 billion by 2024, indicating significant growth potential for Scilex's investment strategy [3]. Strategic Alignment - Scilex aims to leverage its expertise in the biotech sector to guide Datavault in maximizing revenue generation while expanding its market presence [5]. - The collaboration is expected to create a marketplace for Real-World Assets (RWA) in the biotech and pharmaceutical industry, utilizing blockchain technology for ownership representation [3].

ZIBO, China, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Sunrise New Energy Co., Ltd. (“Sunrise”, the “Company”, “we” or “our”) (NASDAQ: EPOW), a leading manufacturer and innovator of battery anode materials, today announced that it has been awarded a grant of approximately RMB 4.3 million (USD 0.59 million) under the National Science and Technology Development Fund. The project aims to accelerate industrial upgrading in Qianxinan prefecture by promoting breakthroughs in the design, precision control, and large-scal ...

BROSSARD, Quebec, Sept. 25, 2025 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using Artificial Intelligence (AI) technologies, announces the voting results of the annual meeting of the shareholders held earlier today. Mr. André Larente, Mr. Robert Dunn, Mr. Michael Braeuel and Mr. Philippe Couillard were elected as directors to hold office until the closing of the next annual meeting of t ...

SAN FRANCISCO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Lockheed Martin Corporation (NYSE: LMT) on behalf of investors who bought shares between January 23, 2024, and July 21, 2025. The lawsuit, Khan v. Lockheed Martin Corporation, alleges the company gave investors a misleading picture of its financial health by failing to disclose that it had inadequate internal controls to assess program risks. Hagens Berman encourages Lockheed Martin investors with subs ...

Heineken N.V. successfully places €2 billion of Notes Amsterdam, 25 September 2025 - Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) announced that it has successfully placed €2 billion of Notes across three tranches today. €500 million 3-year Notes with a coupon of 2.565%;€750 million 8.6-year Notes with a coupon of 3.505%, and€750 million 12-year Notes with a coupon of 3.872%. The Notes will be issued under the Company's Euro Medium Term Note Programme and will be listed on the Luxembourg Stock Exchange. T ...

Heineken N.V. successfully places €2 billion of Notes Amsterdam, 25 September 2025 - Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) announced that it has successfully placed €2 billion of Notes across three tranches today. €500 million 3-year Notes with a coupon of 2.565%;€750 million 8.6-year Notes with a coupon of 3.505%, and€750 million 12-year Notes with a coupon of 3.872%. The Notes will be issued under the Company's Euro Medium Term Note Programme and will be listed on the Luxembourg Stock Exchange. T ...

SAN FRANCISCO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- On September 15, 2025, investors in aTyr Pharma, Inc. (NASDAQ: ATYR) saw the price of their shares crater over 80% after the company reported that its late-stage study of efzofitimod for treating pulmonary sarcoidosis, a significant type of interstitial lung disease (“ILD”), did not meet its main goal. The development and severe market reaction has prompted national shareholders rights firm Hagens Berman to open an investigation into whether aTyr may have mi ...